AI Article Synopsis
- Adipose tissue and cells hold great potential for use in regenerative medicine, but they pose regulatory challenges on both national and international levels.
- The commentary examines the current status of therapies derived from adipose tissue and explores regulatory strategies aimed at ensuring patient safety.
- The goal is to promote the advancement of these therapies in a way that aligns with evidence-based medical practices.
Article Abstract
Although adipose tissue and cells show considerable promise for clinical translation in the emerging field of regenerative medicine, they present a challenge to the regulatory community both nationally and internationally. This commentary evaluates the status of adipose-derived therapeutics and considers regulatory approaches designed to maximize patient safety while advancing clinical translation in accordance with evidence-based medical science.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1089/scd.2019.0096 | DOI Listing |
Publication Analysis
Top Keywords
clinical translation
8
arguments regulatory
4
regulatory categorization
4
categorization framework
4
framework stromal
4
stromal vascular
4
vascular fraction
4
fraction adipose
4
adipose tissue
4
tissue cells
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!